With new therapies that promise to slow Alzheimer’s disease ... - CNN
Jul 16, 2023 · Under new draft guidelines for the diagnosis of Alzheimer’s disease, unveiled on Sunday at a large international gathering of physicians and researchers, these memory tests would take a...
New Drug Approved for Early Alzheimer’s - The New York Times
Jul 2, 2024 · The Food and Drug Administration on Tuesday approved a new drug for Alzheimer’s disease, the latest in a novel class of treatments that has been greeted with hope, disappointment and...
First Alzheimer’s drug to slow disease progression gets full FDA ...
Jul 7, 2023 · CNN — The US Food and Drug Administration on Thursday granted traditional full approval to the Alzheimer’s drug Leqembi, the first medicine proven to slow the course of the memory-robbing...
A Blood Test Accurately Diagnosed Alzheimer’s 90% of the Time, …
Jul 28, 2024 · A Blood Test Accurately Diagnosed Alzheimer’s 90% of the Time, Study Finds - The New York Times. It was much more accurate than primary care doctors using cognitive tests and CT...
Second Alzheimer’s drug to slow disease’s progression may be ... - CNN
Jul 17, 2023 · The full approval this month of the Alzheimer’s drug Leqembi marked a historic shift in the treatment of the disease: For the first time, doctors have a medicine to prescribe that has been...
FDA fully approves Leqembi, first drug shown to slow Alzheimer's ...
Jul 6, 2023 · The Food and Drug Administration has fully approved the first drug shown to slow down Alzheimer's disease. The action means that Leqembi, whose generic name is lecanemab, should be widely...
Start of new era for Alzheimer’s treatment — Harvard Gazette
Jun 5, 2023 · Researchers say we appear to be at the start of a new era for Alzheimer’s treatment. Trial results published in January showed that for the first time a drug has been able to slow the cognitive decline characteristic of the disease.
New Alzheimer’s drug Leqembi is granted full FDA approval - NBC News
Jul 6, 2023 · The Food and Drug Administration has approved lecanemab, a drug developed by Eisai and Biogen with the goal of slowing the progression of Alzheimer’s disease.
FDA approves new Alzheimer's treatment, donanemab from Eli Lilly - CBS News
Jul 3, 2024 · The Food and Drug Administration approved a new Alzheimer's treatment called donanemab on Tuesday, clearing the way for the third addition to a new class of drugs aimed at slowing the brain's...
FDA Grants Accelerated Approval for Alzheimer’s Disease …
January 06, 2023. Today, the U.S. Food and Drug Administration approved Leqembi (lecanemab-irmb) via the Accelerated Approval pathway for the treatment of Alzheimer’s disease. Leqembi is the...
Skip to content